Latest filing published 14 Aug 2026 for SAGIMET BIOSCIENCES INC, €2.8M.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
This profile gathers the share dealings of George Kemble in Sagimet Biosciences Inc. Between 20 July 2026 and 14 August 2026, the trades on record add up to 3 filings.
Not one of the filings records a straightforward purchase or sale on the market. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The record was last updated on 14 August 2026 with a transaction (€2.8M) in Sagimet Biosciences Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations